| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5667794 | J AND J CONSUMER INC | Heartburn treatment |
May, 2015
(8 years ago) | |
|
US5667794 (Pediatric) | J AND J CONSUMER INC | Heartburn treatment |
Nov, 2015
(8 years ago) | |
| US5854267 | J AND J CONSUMER INC | Method for preventing heartburn |
Dec, 2015
(8 years ago) | |
|
US5854267 (Pediatric) | J AND J CONSUMER INC | Method for preventing heartburn |
Jun, 2016
(7 years ago) | |
| US6814978 | J AND J CONSUMER INC | Process for preparing a soft tablet |
Aug, 2021
(2 years ago) | |
|
US6814978 (Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(2 years ago) | |
Pepcid Ac is owned by J And J Consumer Inc.
Pepcid Ac contains Famotidine.
Pepcid Ac has a total of 6 drug patents out of which 6 drug patents have expired.
Expired drug patents of Pepcid Ac are:
- US5667794
- US5667794*PED
- US5854267
- US5854267*PED
- US6814978
- US6814978*PED
Pepcid Ac was authorised for market use on 24 September, 1998.
Pepcid Ac is available in tablet;oral, tablet, chewable;oral dosage forms.
Pepcid Ac can be used as heartburn.
The generics of Pepcid Ac are possible to be released after 26 February, 2022.
Drugs and Companies using FAMOTIDINE ingredient
Market Authorisation Date: 24 September, 1998
Treatment: Heartburn
Dosage: TABLET, CHEWABLE;ORAL; TABLET;ORAL
How can I launch a generic of PEPCID AC before it's drug patent expiration?
More Information on Dosage
PEPCID AC family patents
